|

Access to Genetic Testing in Underserved Patients With Cancer

RECRUITINGN/ASponsored by University of Southern California
Actively Recruiting
PhaseN/A
SponsorUniversity of Southern California
Started2023-10-24
Est. completion2027-10-24
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites

Summary

This study compares the experiences of people who receive information about genetic testing from a computer-generated character to patients who receive information from a human genetics healthcare provider. Patients with cancer are increasingly recommended for genetic testing as standard of care. Multiple factors contribute to low usage of genetic testing but for many patients the lack of access to genetic counseling and testing is an important and flexible factor. Lack of access is especially relevant to racial/ethnic minority patients and those living in non-metropolitan rural settings who are frequently cared for at safety-net hospitals with limited genetics services. Alternative delivery models are necessary to improve rates of access to genetic testing in patients with cancer. Health information technology is under used by genetics providers. A patient-facing relational agent (PERLA) will provide pre-test genetics education in both English and Spanish across two clinical settings to facilitate more timely access to genetic testing. Using the PERLA intervention may help researchers learn different ways to provide education about genetic testing to patients with cancer compared to usual care.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age \> 18 years old
* Diagnosed with least one of the following:

  * Epithelial ovarian cancer
  * Exocrine pancreatic cancer
  * Metastatic or high or very high-risk prostate cancer
  * Breast cancer at or before age 50
  * Bilateral breast cancer
  * Triple negative breast cancer
  * Male breast cancer OR
  * Healthcare provider who treats patients with any of the above types of cancer
* Able to read and write in English or Spanish
* Able to provide informed consent

Exclusion Criteria:

* Patients who cannot provide informed consent
* Patients who cannot see, read, or write
* Patients who have the cancer and clinical characteristics defined in the inclusion criteria, but who do not speak English or Spanish
* Patients with none of the listed cancer diagnoses and clinical characteristics
* Healthcare provider who do not treats cancer patients

Conditions10

Breast CancerBreast CarcinomaCancerMale Breast CarcinomaMalignant Solid NeoplasmMetastatic Prostate CarcinomaOvarian CarcinomaPancreatic Exocrine NeoplasmStage IVB Prostate Cancer American Joint Committee on Cancer v8Triple-Negative Breast Carcinoma

Locations2 sites

California

1 site
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033
Charite Ricker323-409-7710ricker@usc.edu

New York

1 site
University of Rochester
Rochester, New York, 14642

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.